Injectable Drug Compatibility News
New IV Drug Compatibility & Stability - Winter 2021
In this update we added new monographs for ATEZOLIZUMAB and TRILACICLIB. We also added new stability information to COVID-19 VACCINE, mRNA, and to 48 other existing drug monographs. New compatibility information was added to these existing drug monographs: CEFEPIME HYDROCHLORIDE, CISATRACURIUM BESYLATE, DEXMEDETOMIDINE HYDROCHLORIDE, FENTANYL CITRATE, FOSPHENYTOIN, LEVETIRACETAM, NALOXONE HYDROCHLORIDE, NOREPINEPHRINE BITARTRATE, PIPERACILLIN AND TAZOBACTAM, PROPOFOL, VANCOMYCIN HYDROCHLORIDE, and VASOPRESSIN. View Past Updates... Available for pre-order2022 Y-Site Compatibility Wall Charts This 27" x 27" poster is laminated and includes compatibility of 122 drugs and 4 infusion fluids updated with new data that has appeared in the complete King® Guide to...
New IV Drug Compatibility & Stability - Fall 2021
5 New drugs
New compatibility for 38 drugs
New stability for 4 drugs
New IV Drug Compatibility & Stability - Summer 2021
In this update we added new monographs for for COVID-19 VACCINE (JANSSEN), TAFASITAMAB-CXIX, and VILTOLARSEN. We also added new stability information to these existing drug monographs: AMIODARONE HYDROCHLORIDE, AZTREONAM, CEFEPIME HYDROCHLORIDE, CEFTAZIDIME, COVID-19 VACCINE (PFIZER-BIONTECH), IMIPENEM-CILASTATIN, ISOSORBIDE DINITRATE, KETAMINE HYDROCHLORIDE, LORAZEPAM, MEROPENEM, PIPERACILLIN AND TAZOBACTAM, and VALPROATE SODIUM. New compatibility information was added to these existing drug monographs: ALPROSTADIL, CALCIUM GLUCONATE, CEFAZOLIN SODIUM, CEFTAZIDIME, CISATRACURIUM BESYLATE, DEXMEDETOMIDINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, FUROSEMIDE, GENTAMICIN SULFATE, INSULIN, REGULAR, TRAMADOL HYDROCHLORIDE, KETAMINE HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE, MILRINONE HYDROCHLORIDE, NOREPINEPHRINE BITARTRATE, ONDANSETRON HYDROCHLORIDE, PERITONEAL DIALYSIS SOLUTIONS, and VANCOMYCIN HYDROCHLORIDE.
New injectable drug compatibility & stability for Spring 2021
In this update we added new monographs for COVID-19 VACCINE, EPTINEZUMAB-JJMR; IMIPENEM, CILASTATIN, AND RELEBACTAM; and SACITUZUMAB GOVITECAN-HZIY. We also added new stability information to these existing drug monographs: FOSPHENYTOIN SODIUM, METHADONE HYDROCHLORIDE, and MILRINONE LACTATE. New compatibility information was added to these existing drug monographs: ALPROSTADIL, AMIODARONE HYDROCHLORIDE, BUMETANIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE, FENTANYL CITRATE, FUROSEMIDE, HEPARIN SODIUM, MILRINONE LACTATE, NICARDIPINE HYDROCHLORIDE, NITROPRUSSIDE SODIUM, TOTAL PARENTERAL NUTRITION SOLUTIONS, VASOPRESSIN; and IMIPENEM, CILASTATIN, AND RELEBACTAM with nine different parenteral drugs.
COVID-19 Vaccine Product, Storage, & Stability Information
COVID-19 Vaccine Product, Storage, and Stability Information is now available from King Guide. Click To View